Back to Bio-Techne

Bio-Techne News

TECH

Bio‑Techne Merger Approved — Merck KGaA Subsidiary

Shareholders approve merger making Bio‑Techne (TECH) a Merck KGaA subsidiary. FY2025 sales $1.22B; segment breakdown, risks and strategy for investors.

23 September 2026BIO-TECHNE Corp
TECH

Bio-Techne, Merck KGaA Agree Merger

Bio-Techne (TECH) signs merger agreement with Merck KGaA. Analysis of strategic fit, segment exposure, and regulatory risks for investors.

25 June 2026BIO-TECHNE Corp
All news